Gersham Dent is a highly accomplished pharmaceutical industry executive with over 25 years of progressive leadership experience in Central Nervous System and rare diseases clinical research and development. They have held various roles, including Research Scientist II at DuPont Pharmaceuticals and Director at AstraZeneca and Pfizer, leading cross-functional teams and external collaborations in drug development. Gersham earned a PhD in Neurobiology from the University of Delaware and an MBA from Wilmington University, enhancing their expertise in advancing global drug development strategies. Currently, they serve as the Executive Director, Clinical Development for CNS disorders.
This person is not in the org chart
This person is not in any teams
This person is not in any offices